Quite recently, an immunogenic preproinsulin peptide, shown to be ignored by the beta cell-targeted autoimmune reaction in NOD mice, elicited robust amounts of FoxP3+ Tregs in very late-stage pre-diabetes (15-16 weeks of age), and even caused long-term disease remission when started at disease onset (46). This evidence concerns the gene FOXP3 and diabetes mellitus.